Booth 902

Sloiron will showcase its plant-based ferritin-iron supplement ingredient at SupplySide Global. During the event, Libby Weaver, PhD, nutritional biochemist and founder of the food-sourced supplement company Bio Blends, will discuss iron deficiency and Sloiron’s ferritin-iron product at the event, where she will also launch a new book called “Fix Iron First.”

“If there were a holy grail for supplements, it would be an ingredient that supplied iron, the most common nutrient deficiency globally, in a form that was highly bioavailable, without the side effects that conventional iron typically drives,” said Weaver. “Sloiron, a unique form of ferritin-iron from legumes, [sic] is precisely that.”

Weaver will cover the science supporting Sloiron, the importance of correcting iron deficiency, and the development of her new product, Iconic Iron. Weaver has a doctorate in biochemistry, has authored 14 books, and travels globally to speak on topics related to biochemistry, nutrition, and emotions/mindset. The presentation, “Iron: the One Thing that Changes Everything,” will take place on Wednesday, Oct. 29, from 2:00 to 2:20, at the Product Development Theater.

Sloiron is a ferritin-iron sourced from legumes. The iron is contained within the ferritin protein shell, as a mineral called Ferrihydrite. The ferritin ‘cage’ serves as a natural enteric coating for iron and is not broken down in digestion; when it reaches the gut, the gut cell absorbs the ferrihydrite molecule as a whole via a dedicated absorption mechanism, avoiding direct exposure of iron to the gut wall which can cause irritation. In human clinical studies, ferrihydrite has been shown to absorb in humans as well as ferrous sulfate, the company reported.

“Since Sloiron’s introduction to the North American market in 2020, we’ve seen tremendous interest in this unique, bioavailable iron source,” said Vincent Hackel, president and CEO of Sloiron Inc. “Research has substantiated its equivalent absorption to traditional sources without the side effects, and studies are underway to further elucidate the mechanisms of action. We’re pleased to partner with companies looking to create new solutions to address iron deficiency with anemia and optimize human health.”